OLN OLIN Corp
Chemicals & Allied Products · NYSE · SEC CIK 74303 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.7%
TTM net income YoY-531.2%
TTM EPS YoY-519.1%
Revenue 3-yr CAGR-2.2%
Net income 3-yr CAGR—
Margins
Gross margin6.7%
Operating margin-1.9%
Net margin-3.3%
FCF margin3.3%
EBITDA margin5.2%
Returns
ROE-12.2%
ROA-3.0%
ROIC (approx.)-2.2%
Asset turnover0.90x
Leverage & solvency
Liabilities / assets76.8%
Debt / equity1.75x
Current ratio1.45x
Interest coverage-0.71x
Cash quality & payout
Operating cash flow / net income-1.74x
Accruals ratio-8.2%
Payout ratio—
Capex / revenue2.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.75B | $1.74B | $1.58B | $1.67B | $1.71B | $1.76B | $1.64B | $1.67B |
| Cost of revenue | $1.57B | $1.57B | $1.51B | $1.63B | $1.53B | $1.62B | $1.50B | $1.51B |
| Gross profit | $172.70M | $170.20M | $75.80M | $31.30M | $183.40M | $138.10M | $148.70M | $157.90M |
| SG&A expense | $98.40M | $102.70M | $145.00M | $169.00M | $98.10M | $95.20M | $101.00M | $100.30M |
| Operating income | $59.20M | $46.50M | -$78.30M | -$156.50M | $82.80M | $35.30M | $43.70M | $47.30M |
| Interest expense | $44.50M | $44.30M | $43.20M | $50.20M | $45.20M | $45.60M | $48.50M | $44.90M |
| Pretax income | $17.10M | $3.80M | -$118.30M | -$197.90M | $41.50M | -$6.80M | $2.10M | $10.00M |
| Income tax | $2.70M | $17.10M | -$35.30M | -$54.70M | -$2.20M | -$4.00M | $900,000 | -$100,000 |
| Net income | $14.40M | -$13.30M | -$83.00M | -$143.20M | $43.70M | -$2.80M | $1.20M | $10.10M |
| EBITDA | $173.60M | $168.60M | $38.90M | -$30.80M | $216.60M | $165.20M | $175.90M | $176.50M |
| EPS (basic) | 0.13 | -0.12 | -0.73 | — | 0.37 | -0.01 | 0.01 | — |
| EPS (diluted) | 0.13 | -0.12 | -0.73 | — | 0.37 | -0.01 | 0.01 | — |
| Dividends declared per share | 0.20 | 0.20 | 0.20 | — | 0.20 | 0.20 | 0.20 | — |
| Weighted avg. shares (diluted) | 115.00M | 113.90M | 113.80M | — | 115.10M | 114.90M | 116.60M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $214.80M | $177.40M | $192.20M | $167.60M | $140.30M | $223.80M | $174.00M | $175.60M |
| Short-term investments | — | — | — | $0 | — | — | — | $0 |
| Inventory | $862.20M | $847.20M | $827.20M | $784.50M | $966.90M | $919.10M | $875.20M | $823.50M |
| Current assets | $2.20B | $2.19B | $2.10B | $1.97B | $2.26B | $2.29B | $2.25B | $2.08B |
| PP&E, net | $2.05B | $2.09B | $2.13B | $2.20B | $2.21B | $2.26B | $2.27B | $2.33B |
| Goodwill | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.42B | $1.42B |
| Intangibles | $146.40M | $155.60M | $164.80M | $174.40M | $183.40M | $193.70M | $198.60M | $206.60M |
| Total assets | $7.41B | $7.44B | $7.35B | $7.33B | $7.60B | $7.67B | $7.66B | $7.58B |
| Current liabilities | $1.51B | $1.54B | $1.54B | $1.63B | $1.45B | $1.55B | $1.44B | $1.63B |
| Short-term debt | $0 | $0 | $0 | $109.70M | $19.20M | $19.20M | $19.20M | $129.00M |
| Long-term debt | $3.01B | $3.03B | $3.00B | $2.72B | $2.97B | $2.98B | $3.02B | $2.71B |
| Total debt | $3.01B | $3.03B | $3.00B | $2.83B | $2.99B | $3.00B | $3.04B | $2.84B |
| Total liabilities | $5.69B | $5.73B | $5.62B | $5.46B | $5.61B | $5.68B | $5.62B | $5.52B |
| Shareholders' equity | $1.72B | $1.71B | $1.73B | $1.84B | $1.96B | $1.96B | $2.01B | $2.02B |
| Net debt | $2.80B | $2.85B | $2.80B | $2.66B | $2.85B | $2.77B | $2.86B | $2.67B |
| Shares outstanding | 114.00M | 114.00M | 113.90M | 113.60M | 114.10M | 114.60M | 115.10M | 115.70M |
| Cash flow statement | ||||||||
| Operating cash flow | $110.40M | $7.90M | -$48.60M | $321.20M | $26.70M | $212.30M | -$86.00M | $141.70M |
| Capital expenditure | $33.90M | $29.00M | $43.70M | $62.80M | $71.10M | $31.00M | $61.40M | $51.00M |
| Free cash flow | $76.50M | -$21.10M | -$92.30M | $258.40M | -$44.40M | $181.30M | -$147.40M | $90.70M |
| Investing cash flow | -$34.10M | -$32.60M | -$43.00M | -$94.00M | -$73.30M | -$89.90M | -$62.40M | -$76.70M |
| Financing cash flow | -$39.70M | $10.10M | $116.20M | -$199.70M | -$36.70M | -$73.20M | $146.60M | -$113.70M |
| Depreciation & amortization | $114.40M | $122.10M | $117.20M | $125.70M | $133.80M | $129.90M | $132.20M | $129.20M |
| Stock-based compensation | $7.20M | $9.70M | $4.70M | $5.10M | $6.30M | $9.20M | $4.00M | $5.30M |
| Dividends paid | $22.70M | $22.80M | $22.80M | $22.80M | $22.80M | $23.00M | $23.00M | $23.30M |
| Share buybacks | $0 | $0 | $0 | $10.10M | $10.10M | $10.10M | $20.20M | $43.50M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.